I think some may misread my questions regarding IP
Post# of 72447
(Total Views: 237)
Posted On: 09/14/2017 9:06:03 AM
I think some may misread my questions regarding IPIX to indicate doubt of the future of the company and the strength of our science. i doubt there is anyone that has a larger stake in IPIX considering their overall assets than me. I am that confident in mgt, science, trial results, and financial situation. I never considered myself bailing on the company, I considered it merely a strategic retreat as I knew the timeline was in years whereas now it has shortened to mere weeks.
My questions are my way of playing Devil's Advocate and many times point up invalid ideas I had regarding many areas that I am weak in, especially medical trials, small molecule construction and the myriad pathways of illness that is brought to light by the many learned posters we have on board.
My question on B was to hear from those with true medical knowledge to confirm my thoughts as to the gigantic potential of B. Drano's answer made my question worthwhile to many here IMO.
My questions have no agenda or bias, they are strictly to get information from those that speak from a position of knowledge rather than from supposition which more accurately describes my position.
I still am stunned at those that are saying to sell P for $100 MM or so to finance B, even if P comes in killing Otezla and near biologics in efficacy. Talk about giving away a product for pennies on the dollar.
My questions are my way of playing Devil's Advocate and many times point up invalid ideas I had regarding many areas that I am weak in, especially medical trials, small molecule construction and the myriad pathways of illness that is brought to light by the many learned posters we have on board.
My question on B was to hear from those with true medical knowledge to confirm my thoughts as to the gigantic potential of B. Drano's answer made my question worthwhile to many here IMO.
My questions have no agenda or bias, they are strictly to get information from those that speak from a position of knowledge rather than from supposition which more accurately describes my position.
I still am stunned at those that are saying to sell P for $100 MM or so to finance B, even if P comes in killing Otezla and near biologics in efficacy. Talk about giving away a product for pennies on the dollar.
(6)
(0)